Six-Month ResultsFor the first six months of fiscal 2011, revenue decreased 2 percent to $1,910 million. Operating income declined to $208 million from $244 million. Income from continuing operations was $114 million, or $0.51 per diluted share.
Excluding nonrecurring items, adjusted operating income for the first six months of fiscal 2011 decreased to $277 million from $283 million and adjusted income from continuing operations decreased $9 million to $165 million, or $0.73 on an adjusted basis per diluted share.
Operating expenses, including SG&A, R&D, and restructuring and acquisition integration charges in the first six months of fiscal 2011 totaled $707 million or 37 percent of total revenue. Excluding $69 million of nonrecurring items, adjusted operating expenses in the first six months of fiscal 2011 totaled $638 million, or 33 percent of total revenue. Adjusted SG&A expenses were $562 million, and R&D investments totaled $76 million.
Segment results for the six months ended Dec. 31, 2010 and 2009 are as follows:Critical Care Technologies1H FY111H FY10Y/YRevenue
(15)%Adjusted Segment Profit
(4)%Medical Technologies & Services1H FY111H FY10Y/YRevenue
(16)%Adjusted Segment Profit
9%Adjusted operating expenses, adjusted SG&A expenses, adjusted operating income, adjusted income from continuing operations, adjusted diluted earnings per share and adjusted segment profit are non-GAAP financial
|SOURCE CareFusion Corp.|
Copyright©2010 PR Newswire.
All rights reserved